La Jolla Pharmaceutical Company EPS - Earnings per Share 2010-2022 | LJPC
La Jolla Pharmaceutical Company eps - earnings per share from 2010 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| La Jolla Pharmaceutical Company Annual EPS |
| 2021 |
$0.58 |
| 2020 |
$-1.44 |
| 2019 |
$-4.30 |
| 2018 |
$-7.85 |
| 2017 |
$-5.41 |
| 2016 |
$-4.54 |
| 2015 |
$-2.68 |
| 2014 |
$-2.00 |
| 2013 |
$-12.16 |
| 2012 |
$-41.77 |
| 2011 |
$-1,579.50 |
| 2010 |
$-250.00 |
| 2009 |
$-0.14 |
| La Jolla Pharmaceutical Company Quarterly EPS |
| 2022-06-30 |
$0.08 |
| 2022-03-31 |
$0.00 |
| 2021-12-31 |
$0.13 |
| 2021-09-30 |
$-0.08 |
| 2021-06-30 |
$0.11 |
| 2021-03-31 |
$0.42 |
| 2020-12-31 |
$-0.12 |
| 2020-09-30 |
$-0.43 |
| 2020-06-30 |
$-0.57 |
| 2020-03-31 |
$-0.32 |
| 2019-12-31 |
$-0.93 |
| 2019-09-30 |
$-1.08 |
| 2019-06-30 |
$-1.12 |
| 2019-03-31 |
$-1.17 |
| 2018-12-31 |
$-1.68 |
| 2018-09-30 |
$-1.93 |
| 2018-06-30 |
$-2.02 |
| 2018-03-31 |
$-2.22 |
| 2017-12-31 |
$-1.75 |
| 2017-09-30 |
$-1.19 |
| 2017-06-30 |
$-1.21 |
| 2017-03-31 |
$-1.26 |
| 2016-12-31 |
$-1.45 |
| 2016-09-30 |
$-1.23 |
| 2016-06-30 |
$-0.90 |
| 2016-03-31 |
$-0.96 |
| 2015-12-31 |
$-0.69 |
| 2015-09-30 |
$-0.70 |
| 2015-06-30 |
$-0.70 |
| 2015-03-31 |
$-0.59 |
| 2014-12-31 |
$-0.17 |
| 2014-09-30 |
$-0.37 |
| 2014-06-30 |
$-0.53 |
| 2014-03-31 |
$-0.93 |
| 2013-12-31 |
$12.32 |
| 2013-09-30 |
$-5.45 |
| 2013-06-30 |
$-6.77 |
| 2013-03-31 |
$-12.26 |
| 2012-12-31 |
$0.73 |
| 2012-09-30 |
$-9.00 |
| 2012-06-30 |
$-33.50 |
| 2012-03-31 |
$0.00 |
| 2011-12-31 |
$-1,250.50 |
| 2011-09-30 |
$14.00 |
| 2011-06-30 |
$0.50 |
| 2011-03-31 |
$-343.50 |
| 2010-12-31 |
$36,300.00 |
| 2010-09-30 |
$-2,450.00 |
| 2010-06-30 |
$-20,650.00 |
| 2010-03-31 |
$-13,450.00 |
| 2009-12-31 |
$-0.02 |
| 2009-09-30 |
$-0.01 |
| 2009-06-30 |
$-0.03 |
| 2009-03-31 |
$-0.08 |
